Homozygous mutations in BRIP1/FANCJ result in FA phenotype (Kumaraswamy & Shiekhattar, 2007), while heterozygous truncating mutations are associated with a moderate risk of breast cancer (Levran et al., 2005; Seal et al., 2006; Walsh & King, 2007). This evidence concerns the gene BRIP1 and breast cancer.